Lisinopril and Hydrochlorothiazide Tablets USP — Class II drug recall D-1720-2019
Terminated recall by Lupin Pharmaceuticals Inc., reported 2019-08-21, distributed nationwide. Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets
| Recall number | D-1720-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2019-07-17 |
| Classified | 2019-08-09 |
| Reported by FDA | 2019-08-21 |
| Terminated | 2020-09-14 |
| Distributed | Nationwide (US) |
| Quantity | 39,216 bottles |
| NDC | 68180-0518, 68180-0518-01, 68180-0518-02, 68180-0518-30, 68180-0519, 68180-0519-01, 68180-0519-02, 68180-0519-30, 68180-0520, 68180-0520-01, 68180-0520-02, 68180-0520-30 |
| Lot numbers | H900575 |
| Expiration dates | 2022-01 |
Product
Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle, Rx only, Manufactured by for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by: Lupin Limited, Pithampur, INDIA NDC 68180-518-01
Reason for recall
Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1720-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.